{"id":"https://openalex.org/W2580016367","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.tps9080","title":"A multi-center phase II open-label study (CheckMate 204) to evaluate safety and efficacy of nivolumab (NIVO) in combination with ipilimumab (IPI) followed by NIVO monotherapy in patients (pts) with melanoma (MEL) metastatic to the brain.","display_name":"A multi-center phase II open-label study (CheckMate 204) to evaluate safety and efficacy of nivolumab (NIVO) in combination with ipilimumab (IPI) followed by NIVO monotherapy in patients (pts) with melanoma (MEL) metastatic to the brain.","publication_year":2015,"publication_date":"2015-05-20","ids":{"openalex":"https://openalex.org/W2580016367","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.tps9080","mag":"2580016367"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2015.33.15_suppl.tps9080","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.tps9080","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.tps9080","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084347950","display_name":"Kim Allyson Margolin","orcid":"https://orcid.org/0000-0002-5248-4356","observed_orcids":["https://orcid.org/0000-0002-5248-4356","https://orcid.org/0000-0002-5718-7422"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kim Allyson Margolin","raw_affiliation_strings":["Stanford University Medical Center and the Cytokine Working Group (CWG), Stanford, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University Medical Center and the Cytokine Working Group (CWG), Stanford, CA","institution_ids":["https://openalex.org/I4210137306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056045921","display_name":"Hussein Abdul-Hassan Tawbi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hussein Abdul-Hassan Tawbi","raw_affiliation_strings":["University of Pittsburgh Cancer Inst, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Inst, Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089516753","display_name":"Marc S. Ernstoff","orcid":"https://orcid.org/0000-0002-8132-7069","observed_orcids":["https://orcid.org/0000-0002-8132-7069"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc S. Ernstoff","raw_affiliation_strings":["Cleveland Clinic Foundation and the Cytokine Working Group (CWG), Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation and the Cytokine Working Group (CWG), Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084967339","display_name":"Frank Stephen Hodi","orcid":"https://orcid.org/0000-0001-6825-091X","observed_orcids":["https://orcid.org/0000-0001-6825-091X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"F. Stephen Hodi","raw_affiliation_strings":["Dana-Farber Cancer Institute and the Cytokine Working Group (CWG), Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute and the Cytokine Working Group (CWG), Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007052233","display_name":"David F. McDermott","orcid":"https://orcid.org/0000-0002-2675-5095","observed_orcids":["https://orcid.org/0000-0002-2675-5095","https://orcid.org/0000-0001-6978-0867"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David F. McDermott","raw_affiliation_strings":["Beth Israel Deaconess Medical Center and the Cytokine Working Group (CWG), Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center and the Cytokine Working Group (CWG), Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074629137","display_name":"Robin H. Edwards","orcid":"https://orcid.org/0000-0002-7423-3638","observed_orcids":["https://orcid.org/0000-0002-7423-3638"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin Edwards","raw_affiliation_strings":["Bristol-Myers Squibb, Plainsboro, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Plainsboro, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043119574","display_name":"Alexandre Avila","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandre Avila","raw_affiliation_strings":["Bristol-Myers Squibb, Plainsboro, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Plainsboro, NJ","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052526230","display_name":"Michael B. Atkins","orcid":"https://orcid.org/0000-0003-3901-9924","observed_orcids":["https://orcid.org/0000-0003-3901-9924"]},"institutions":[{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael B. Atkins","raw_affiliation_strings":["Georgetown-Lombardi Comprehensive Cancer Center and the Cytokine Working Group (CWG), Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown-Lombardi Comprehensive Cancer Center and the Cytokine Working Group (CWG), Washington, DC","institution_ids":["https://openalex.org/I4390039356"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"15_suppl","first_page":"TPS9080","last_page":"TPS9080"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.8008000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.8008000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.19449999928474426,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.8949999809265137},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":1.0},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.7129999995231628},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9279999732971191},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7300000190734863},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.796999990940094},{"id":"https://openalex.org/keywords/ctla-4-inhibitors","display_name":"CTLA-4 inhibitors","score":1.0},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.8090000152587891},{"id":"https://openalex.org/keywords/stereotactic-radiotherapy","display_name":"stereotactic radiotherapy","score":0.777999997138977},{"id":"https://openalex.org/keywords/central-nervous-system-response","display_name":"central nervous system response","score":0.6840000152587891},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6629999876022339},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.6470000147819519},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8799999952316284},{"id":"https://openalex.org/keywords/leptomeningeal-metastasis","display_name":"leptomeningeal metastasis","score":0.6700000166893005},{"id":"https://openalex.org/keywords/whole-brain-radiotherapy","display_name":"whole brain radiotherapy","score":0.7300000190734863},{"id":"https://openalex.org/keywords/stereotactic-radiosurgery","display_name":"stereotactic radiosurgery","score":0.597000002861023},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-related-pneumonitis","display_name":"immune-related pneumonitis","score":0.4490000009536743},{"id":"https://openalex.org/keywords/immune-mediated-colitis","display_name":"immune-related colitis","score":0.6069999933242798},{"id":"https://openalex.org/keywords/immune-related-endocrinopathy","display_name":"immune-related endocrinopathy","score":0.6069999933242798},{"id":"https://openalex.org/keywords/immune-related-dermatitis","display_name":"immune-related dermatitis","score":0.5559999942779541},{"id":"https://openalex.org/keywords/immune-related-encephalitis","display_name":"immune-related encephalitis","score":0.6610000133514404},{"id":"https://openalex.org/keywords/immune-related-hypophysitis","display_name":"immune-related hypophysitis","score":0.5789999961853027}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.922140896320343},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.7560268640518188},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.6785520315170288},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.604834794998169},{"id":"https://openalex.org/C2778164965","wikidata":"https://www.wikidata.org/wiki/Q1620196","display_name":"Brain metastasis","level":4,"score":0.5118646025657654},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5036415457725525},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4934040606021881},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44986438751220703},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.44894999265670776},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.2809322476387024},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2797773778438568},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.24113214015960693}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2015.33.15_suppl.tps9080","doi":"https://doi.org/10.1200/jco.2015.33.15_suppl.tps9080","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2015.33.15_suppl.tps9080","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2890815045","https://openalex.org/W2946844252","https://openalex.org/W2482589824","https://openalex.org/W3204525381","https://openalex.org/W4379280917","https://openalex.org/W4242821526","https://openalex.org/W2946833462","https://openalex.org/W2905942491","https://openalex.org/W7201872007","https://openalex.org/W3089137385"],"abstract_inverted_index":{"TPS9080":[0],"Background:":[1],"Brain":[2],"metastasis":[3],"develops":[4],"in":[5,71,141,251],"approximately":[6,119],"50%":[7,120],"of":[8,23,84,121,136,155,160,204],"pts":[9,73,108,123,304],"with":[10,74,101,109,138,145,152,179,282],"metastatic":[11,111],"MEL.":[12,62],"In":[13,63],"these":[14],"pts,":[15],"progressive":[16],"brain":[17,78,147,162],"disease":[18,165,234],"is":[19,94,116,218],"the":[20,82,95,113,221],"major":[21],"cause":[22],"tumor-related":[24],"death":[25],"(median":[26],"overall":[27],"survival":[28],"[OS]":[29],"after":[30],"diagnosis,":[31],"4":[32,187],"months).":[33],"NIVO":[34,99,105,175,191],"(a":[35,46],"fully":[36,47],"human":[37,48],"IgG4":[38],"PD-1":[39],"immune":[40,51],"checkpoint":[41,52],"inhibitor":[42,53],"antibody)":[43,54],"and":[44,77,144,254,261,286,294],"IPI":[45,68,102,180],"IgG1":[49],"CTLA-4":[50],"are":[55,149,266,298],"each":[56],"approved":[57],"as":[58],"monotherapy":[59,106,192],"for":[60,107,202],"advanced":[61,75],"a":[64,153,158,205],"phase":[65,91],"II":[66,92],"study,":[67,86],"showed":[69],"activity":[70],"some":[72],"MEL":[76,110,139],"metastases.":[79],"Building":[80],"upon":[81],"success":[83],"that":[85,118],"this":[87,243,252],"open-label,":[88],"multi-site,":[89],"US,":[90],"study":[93],"first":[96],"to":[97,112,219,256,267],"evaluate":[98],"combined":[100,178],"followed":[103,189],"by":[104,190],"brain.":[114],"It":[115],"anticipated":[117],"enrolled":[122],"will":[124,169,173,212,305],"have":[125],"had":[126],"prior":[127],"stereotactic":[128],"radiotherapy":[129],"(SRT).":[130],"Methods:":[131],"Pts":[132,151,172],"\u2265":[133,236],"18":[134],"years":[135],"age":[137],"measurable":[140],"extracranial":[142,269,285],"sites":[143],"asymptomatic":[146],"metastases":[148],"eligible.":[150],"history":[154,159],"leptomeningeal":[156],"involvement,":[157],"whole":[161],"irradiation,":[163],"autoimmune":[164],"or":[166,198],"corticosteroid":[167],"use":[168],"be":[170,213,306],"excluded.":[171],"receive":[174],"1":[176],"mg/kg":[177,182,194],"3":[181,193],"every":[183],"three":[184],"weeks":[185],"(Q3W;":[186],"doses),":[188],"Q2W":[195],"until":[196],"progression":[197,203],"unacceptable":[199],"toxicity.":[200],"SRT":[201],"single":[206],"central":[207],"nervous":[208],"system":[209],"(CNS)":[210],"lesion":[211],"permitted.":[214],"The":[215],"primary":[216],"objective":[217,259],"assess":[220,268],"CNS":[222],"clinical":[223],"benefit":[224],"rate":[225],"(CBR;":[226],"complete":[227],"response":[228,231,241,260,291],"+":[229,232],"partial":[230],"stable":[233],"[SD]":[235],"6":[237],"months)":[238],"per":[239,271,279,289],"protocol-defined":[240],"criteria;":[242,292],"endpoint":[244],"was":[245],"selected":[246],"based":[247],"on":[248],"its":[249],"relevance":[250],"population":[253],"ability":[255],"capture":[257],"both":[258],"durable":[262],"SD.":[263],"Secondary":[264],"objectives":[265],"CBR":[270,275,288],"RECIST":[272,280],"v1.1;":[273],"global":[274,287],"(CNS":[276],"plus":[277],"extracranial)":[278],"v1.1":[281],"modifications;":[283],"CNS,":[284],"immune-related":[290],"OS":[293],"safety.":[295],"Exploratory":[296],"correlates":[297],"also":[299],"planned.":[300],"An":[301],"estimated":[302],"110":[303],"enrolled.":[307],"Clinical":[308,313],"trial":[309,314],"registration":[310],"number:":[311],"NCT02320058.":[312,316],"information:":[315]},"counts_by_year":[{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-02-03T00:00:00"}